The Recall Desk

Severity 4 of 5

Severe recalls

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

What “severe” means here

Severity 4 (Severe) recalls have a real, documented risk of significant injury, hospitalization, or property damage even if no deaths have been reported. The agency classification is FDA Class II with hospitalization reports, USDA Class I, or a structural vehicle defect. These need attention quickly — not five-alarm urgency but not something to put off. Examples include allergen mislabeling on common allergens for products eaten by children, drug potency out of specification by a margin that could cause measurable harm, and vehicle defects affecting braking or steering.

The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.

23026–23050 of 32176

  • SevereFDA (Food)·F-2034-2015·2015-05-06

    Giant Eagle Danish With Fruit Recalled for Undeclared Egg

    Giant Eagle is recalling Danish With Fruit products due to undeclared egg. Consumers with this product should not eat it.

    Product
    DANISH WITH FRUIT 2 COUNT; PLU: 69779; NET WT 6.0 oz.; CONTAINS: WHEAT, SOY, MILK; In clear plastic clamshell
    Category
    Food
    Distribution
    4 states
  • SevereFDA (Food)·F-2076-2015·2015-05-06

    Hope Foods Recalls Kale Pesto Hummus for Undeclared Walnuts

    Hope Foods is voluntarily recalling one lot of Kale Pesto Hummus because it contains undeclared walnuts. Consumers should check for the specific lot code and UPC.

    Product
    Organic Hummus HOPE Kale Pesto Spread Good Things, Net Wr 8 oz (227g), Best By date of 05/04/15.
    Category
    Food
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0971-2015·2015-05-06

    Teva Recalls Fluoxetine Capsules Due to Residual Solvent Impurity

    Teva Pharmaceuticals USA is recalling specific lots of Fluoxetine Capsules USP, 20 mg, due to an elevated level of a residual solvent impurity in the active pharmaceutical ingredient.

    Product
    FLUOXETINE — FLUOXETINE (FLUOXETINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereNHTSA·15V261000·2015-05-05

    Mercedes-Benz Recalls 2015 Sprinter Vehicles Due to Oil Leak Fire Risk

    Mercedes-Benz is recalling 2015 Sprinter 2500 and 3500 vehicles because oil may leak from the chain tensioner gasket, posing a fire and road hazard risk.

    Product
    MERCEDES BENZ — MERCEDES BENZ SPRINTER 3500, SPRINTER 2500
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·15V264000·2015-05-05

    Eldorado Amerivan 10 Recall for Rear Shock Absorber Separation Risk

    Eldorado is recalling 2012-2015 Amerivan 10 vehicles because the rear shock absorber may separate, potentially damaging fuel lines and causing a fire.

    Product
    ELDORADO — ELDORADO AMERIVAN 10
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·15V262000·2015-05-05

    Gillig Low Floor Vehicles Recalled for Engine Oil Fire Risk

    Gillig is recalling 2010-2015 Low Floor vehicles because a vent tube may detach, allowing engine oil to contact hot surfaces and cause a fire.

    Product
    GILLIG — GILLIG LOW FLOOR
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereNHTSA·15V259000·2015-05-04

    Jayco Eagle Fifth Wheel Trailer Recall for Wheel Stud Defect

    Jayco is recalling 2016 Eagle fifth wheel trailers because wheel studs may break, potentially causing the wheel to detach and increasing crash risk.

    Product
    JAYCO FIFTH WHEEL — JAYCO FIFTH WHEEL EAGLE
    Category
    Vehicle
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-887-2015·2015-04-29

    Attix Pharmaceuticals Recalls Satraplatin Due to Penicillin Cross Contamination Risk

    Attix Pharmaceuticals is recalling Satraplatin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Satraplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-711-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hydralazine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Hydralazine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Hydralazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-756-2015·2015-04-29

    Attix Pharmaceuticals Recalls Levocetirizine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Levocetirizine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Levocetirizine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-511-2015·2015-04-29

    Attix Pharmaceuticals Recalls Amikacin Sulfate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Amikacin Sulfate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Amikacin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-834-2015·2015-04-29

    Attix Pharmaceuticals Recalls Paroxetine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Paroxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Paroxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-867-2015·2015-04-29

    Progesterone API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling progesterone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Progesterone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-611-2015·2015-04-29

    Attix Pharmaceuticals Recalls Dantrolene Sodium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Dantrolene Sodium API lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Dantrolene Sodium (Light Yellow) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-500-2015·2015-04-29

    Attix Pharmaceuticals Recalls Acetylsalicyclic Acid Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling acetylsalicyclic acid active pharmaceutical ingredient due to potential penicillin cross-contamination. The product was distributed to compounding pharmacies and research organizations.

    Product
    Acetylsalicyclic acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0969-2015·2015-04-29

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Human Hair Particulate

    Hospira is recalling 0.9% Sodium Chloride Injection, USP, 250 mL, because a human hair was found sealed in the bag at the additive port area.

    Product
    0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-694-2015·2015-04-29

    Attix Pharmaceuticals Recalls Furazolidine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Furazolidine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Furazolidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Devices)·Z-1498-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Specification Defects

    Wright Medical Technology is recalling 100 units of Crosscheck Plating Systems because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, Utility Plate, 6-Hole, REF CCP-UTN6. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-874-2015·2015-04-29

    Attix Pharmaceuticals Recalls Quinine Sulfate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Quinine Sulfate Dihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Quinine Sulfate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-706-2015·2015-04-29

    Attix Pharmaceuticals Recalls Histamine Phosphate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Histamine Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Histamine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-589-2015·2015-04-29

    Attix Pharmaceuticals Recalls Cisatracurium Besylate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Cisatracurium Besylate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Cisatracurium Besylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-665-2015·2015-04-29

    Attix Pharmaceuticals Recalls Etomidate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Etomidate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Etomidate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-586-2015·2015-04-29

    Attix Pharmaceuticals Recalls Cimetidine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Cimetidine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Cimetidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Food)·F-2022-2015·2015-04-29

    Giant Eagle Recalls Japanese Breaded Cod Fillet for Undeclared Soy

    Giant Eagle is recalling Japanese Breaded Cod Fillet because it contains undeclared soy, a major food allergen.

    Product
    Giant Eagle Japanese Breaded Cod Fillet various weights Contains: Fish, Wheat, Milk, Egg Dist. By: Giant Eagle Mkts. Co., Pittsburgh, PA 15238 Sell by: (up to and including) 3/26/2015 Sold on foam trays with flexible plastic overwrap.
    Category
    Food
    Distribution
    0 states